In a paper in the August 2012 Arthritis & Rheumatology, the Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the ACR SLE classification criteria, based on evidence from 1,400 ... The ACR agreed this year to support a
Hydroxychloroquine, an antimalaria medication, appears to be an effective treatment for both lupus and rheumatoid arthritis. ... In the lupus study, the drug protected against kidney damage, a common complication of lupus.
Belimumab (Benlysta) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving standard therapy. ... The intravenous infusion is the first lupus drug to be approved in 50 years.
QD: News Every Day-- Marijuana not recommended for rheumatological conditions. Evidence doesn't support medical marijuana for rheumatological conditions such as arthritis, lupus or fibromyalgia, a review found.
Since February there is a shortage of both drugs and this is a problem for patients who need it to treat lupus, rheumatoid arthritis, or malaria.
Prescriptions filled were diclofenac, Naprosyn, Celebrex and ibuprofen. The researchers controlled for other miscarriage risks like diabetes, depression, rheumatoid arthritis, lupus and untreated thyroid disease.
So if I'm going to get lymphoma or lupus or pernicious anemia or myriad other illnesses, there's absolutely no reason for me to do a thing about it until
This has happened before. A variety of different types of arthritis that can now be diagnosed quite precisely as rheumatoid arthritis, or osteoarthritis, or Lupus arthritis, were once a syndrome of
Which of the following is the mostlikely diagnosis? A: Livedo reticularisB: Lyme diseaseC: Subacute cutaneous lupus erythe-. ... matosusD: Systemic lupus erythematosus. See Test Yourself, page 16, for answer.
SCLE occurs in up to 10% of patients with systemic lupus erythematosus (SLE), usually with some of the less serious SLE manifestations (arthritis, serositis), and is associated with anti-Ro/SSA ... Up to 50% of patients with subacute cutaneous lupus